ESC
A proposed multi-ingredient liver health blend combining botanical compounds and selected nutrients, with a delivery concept for the lipophilic fraction.
Exploratory pilot · mean IU/L · identical 0–100 scales in every panel.
Uncontrolled, open-label pilot; n=60. All participants also began diet and exercise. The formulation's effect cannot be isolated. The revised LIVENTRA blend differs from the studied HEPASLIM formulation. Chart values rounded to one decimal.
A proposed multi-ingredient blend built around botanical compounds and selected nutrients for metabolic, inflammatory-balance, antioxidant and hepatocyte support.
Inositol · Ursolic acid · Sulforaphane.
Baicalin · Curcumin · Quercetin.
Resveratrol · EGCG · Gallic acid.
Silybin · Andrographolide · Tanshinones.
These are potential positioning areas, not established Q-Liventra health benefits. Product-specific substantiation is required.
Several of the formulation's botanical actives sit in the lipophilic fraction, which can face poor dissolution and limited systemic exposure. Q-LIVENTRA pairs two QuanticSphere™ technologies — one for its phytosome actives, one for its minerals — giving brands a liver-health proposition built around engineered delivery.
Phytosome-complexed nanosphere vesicles provide gastroprotective shielding, improved dissolution, enhanced uptake, and increased systemic exposure.
Minerals (Mg, Mn) are nano-chelated within a biopolymer matrix. They are protected from gastric conditions and released at intestinal pH for optimized mineral delivery.
Several of Q-Liventra's botanical actives sit in the lipophilic fraction, which can face poor dissolution and limited systemic exposure. Q-LIVENTRA is designed to address that delivery challenge with QuanticSphere™ PQNS and MIBS technology.
In an uncontrolled, open-label pilot (n=60), participants who also began diet and exercise alongside the studied formulation showed mean ALT, AST and GGT reductions of 54.3%, 55.2% and 52.9% respectively from baseline to week 12. The formulation's own effect cannot be isolated from diet and exercise, and the studied formulation was HEPASLIM — the revised Q-Liventra blend differs from it. This is exploratory data, not a substantiated health claim for Q-Liventra.
QuanticSphere™ PQNS (Phytosome Quantum Nano Sphere) uses phytosome-complexed nanosphere vesicles for gastroprotective shielding, improved dissolution, enhanced uptake and increased systemic exposure. QuanticSphere™ MIBS (Mineral Ion Biopolymer Sphere) nano-chelates minerals (Mg, Mn) within a biopolymer matrix, protecting them from gastric conditions and releasing them at intestinal pH for optimized mineral delivery.
Healthy liver function support, normal fat digestion support, and antioxidant support. These are potential positioning areas, not established Q-Liventra health benefits — product-specific substantiation is required.
Facility: NSF/ANSI 455-2 certified GMP, FSSC 22000, ISO 9001/14001/45001. Regulatory: 21 CFR Part 111, Halal Certified. Dissolution: approximately 95–100% release, batch-consistent. IP: QuanticSphere™ PQNS, patent pending 202521095813.
Share your formulation requirements and our team can walk you through the full Q-Liventra clinical dossier, supply format and technical specifications.
Talk to a Specialist